DermWire TV

Episodes 17-32 of 121

FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
DermWire TV
FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWire TV
FDA Approves Axillary Hyperhidrosis Treatment; Study Examines Biologic Outcomes in Psoriasis
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
Skin Cancer & Photoprotection
DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
- Neal Bhatia, MD, FAAD
- Todd E. Schlesinger, MD
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Atopic Dermatitis
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
- Alexandra Golant, MD, FAAD
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermWire TV
DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermWire TV
DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermWire TV
DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermWire TV
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWire TV
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWire TV
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWire TV
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWire TV
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
DermWire TV
First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
DermWireTV: International Launch of AviClear; Biological Effects of Air Pollution on Human Skin; New AAD Guidelines for Acne Care
DermWireTV: International Launch of AviClear; Biological Effects of Air Pollution on Human Skin; New AAD Guidelines for Acne Care
DermWire TV
DermWireTV: International Launch of AviClear; Biological Effects of Air Pollution on Human Skin; New AAD Guidelines for Acne Care
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
DermWire TV
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
DermWire TV
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?

2/7